Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.

Scheich S, Lindner S, Koenig R, Reinheimer C, Wichelhaus TA, Hogardt M, Besier S, Kempf VAJ, Kessel J, Martin H, Wilke AC, Serve H, Bug G, Steffen B.

Cancer. 2018 Jan 15;124(2):286-296. doi: 10.1002/cncr.31045. Epub 2017 Sep 28.

2.

DEVELOPMENT OF REFERENCE RANGES FOR PLASMA TOTAL CHOLINESTERASE AND BRAIN ACETYLCHOLINESTERASE ACTIVITY IN FREE-RANGING CARNABY'S BLACK-COCKATOOS (CALYPTORHYNCHUS LATIROSTRIS).

Vaughan-Higgins R, Vitali S, Reiss A, Besier S, Hollingsworth T, Smith G.

J Wildl Dis. 2016 Jul;52(3):592-8. doi: 10.7589/2015-02-047. Epub 2016 May 19.

PMID:
27195690
3.

Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors.

Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H, Brandt C, Besier S, Wichelhaus TA.

Int J Med Microbiol. 2013 Dec;303(8):405-9. doi: 10.1016/j.ijmm.2013.05.002. Epub 2013 May 10.

PMID:
23770266
4.

Antimicrobial activities of trimethoprim/sulfamethoxazole, 5-iodo-2'-deoxyuridine and rifampicin against Staphylococcus aureus.

Zander J, Besier S, Faetke S, Saum SH, Müller V, Wichelhaus TA.

Int J Antimicrob Agents. 2010 Dec;36(6):562-5. doi: 10.1016/j.ijantimicag.2010.08.007. Epub 2010 Oct 13.

PMID:
20947313
5.

Multistep virtual screening for rapid and efficient identification of non-nucleoside bacterial thymidine kinase inhibitors.

Zander J, Hartenfeller M, Hähnke V, Proschak E, Besier S, Wichelhaus TA, Schneider G.

Chemistry. 2010 Aug 16;16(31):9630-7. doi: 10.1002/chem.201001347.

PMID:
20648496
6.

Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.

Zander J, Besier S, Ackermann H, Wichelhaus TA.

Antimicrob Agents Chemother. 2010 Mar;54(3):1226-31. doi: 10.1128/AAC.00705-09. Epub 2009 Dec 22.

7.

Mutational analyses of the BbCRASP-1 protein of Borrelia burgdorferi identify residues relevant for the architecture and binding of host complement regulators FHL-1 and factor H.

Kraiczy P, Hanssen-Hübner C, Kitiratschky V, Brenner C, Besier S, Brade V, Simon MM, Skerka C, Roversi P, Lea SM, Stevenson B, Wallich R, Zipfel PF.

Int J Med Microbiol. 2009 Apr;299(4):255-68. doi: 10.1016/j.ijmm.2008.09.002. Epub 2009 Jan 9.

PMID:
19138559
8.

Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease.

Besier S, Zander J, Siegel E, Saum SH, Hunfeld KP, Ehrhart A, Brade V, Wichelhaus TA.

J Clin Microbiol. 2008 Nov;46(11):3829-32. doi: 10.1128/JCM.01440-08. Epub 2008 Oct 1.

9.

The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.

Besier S, Zander J, Kahl BC, Kraiczy P, Brade V, Wichelhaus TA.

Antimicrob Agents Chemother. 2008 Jun;52(6):2183-9. doi: 10.1128/AAC.01395-07. Epub 2008 Mar 31.

10.

Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.

Besier S, Ludwig A, Zander J, Brade V, Wichelhaus TA.

Antimicrob Agents Chemother. 2008 Apr;52(4):1570-2. doi: 10.1128/AAC.01098-07. Epub 2008 Jan 22.

11.

Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus.

Zander J, Besier S, Saum SH, Dehghani F, Loitsch S, Brade V, Wichelhaus TA.

Infect Immun. 2008 Apr;76(4):1333-9. Epub 2007 Dec 26.

12.

[Subcutaneous emphysema of unusual extent].

Besier S, Bingold TM, Walcher F, Engels K, Spellerberg B, Brade V, Brandt C.

Chirurg. 2007 Dec;78(12):1148-51. German.

PMID:
17431554
13.

Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus.

Besier S, Ludwig A, Ohlsen K, Brade V, Wichelhaus TA.

Int J Med Microbiol. 2007 Jul;297(4):217-25. Epub 2007 Apr 6.

PMID:
17412637
14.

Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease.

Besier S, Smaczny C, von Mallinckrodt C, Krahl A, Ackermann H, Brade V, Wichelhaus TA.

J Clin Microbiol. 2007 Jan;45(1):168-72. Epub 2006 Nov 15.

15.

[Spontaneous gas gangrene in a diabetic patient with Clostridium septicum].

Mischke A, Besier S, Walcher F, Waibel H, Brade V, Brandt C.

Chirurg. 2005 Oct;76(10):983-6. German.

PMID:
16021394
16.
17.
18.

Selection of ketolide resistance in Staphylococcus aureus.

Besier S, Hunfeld KP, Giesser I, Schäfer V, Brade V, Wichelhaus TA.

Int J Antimicrob Agents. 2003 Jul;22(1):87-8. No abstract available.

PMID:
12842336
19.

Molecular analysis of fusidic acid resistance in Staphylococcus aureus.

Besier S, Ludwig A, Brade V, Wichelhaus TA.

Mol Microbiol. 2003 Jan;47(2):463-9.

20.

Biological cost of rifampin resistance from the perspective of Staphylococcus aureus.

Wichelhaus TA, Böddinghaus B, Besier S, Schäfer V, Brade V, Ludwig A.

Antimicrob Agents Chemother. 2002 Nov;46(11):3381-5.

Supplemental Content

Loading ...
Support Center